These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 37868979)

  • 21. A novel human Her-2/neu chimeric molecule expressed by Listeria monocytogenes can elicit potent HLA-A2 restricted CD8-positive T cell responses and impact the growth and spread of Her-2/neu-positive breast tumors.
    Seavey MM; Pan ZK; Maciag PC; Wallecha A; Rivera S; Paterson Y; Shahabi V
    Clin Cancer Res; 2009 Feb; 15(3):924-32. PubMed ID: 19188163
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Flickinger JC; Rodeck U; Snook AE
    Vaccines (Basel); 2018 Jul; 6(3):. PubMed ID: 30044426
    [No Abstract]   [Full Text] [Related]  

  • 23. Listeria-based vaccines for cancer treatment.
    Paterson Y; Maciag PC
    Curr Opin Mol Ther; 2005 Oct; 7(5):454-60. PubMed ID: 16248280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Central nervous system tumor immunity generated by a recombinant listeria monocytogenes vaccine targeting tyrosinase related protein-2 and real-time imaging of intracranial tumor burden.
    Prins RM; Bruhn KW; Craft N; Lin JW; Kim CH; Odesa SK; Miller JF; Liau LM
    Neurosurgery; 2006 Jan; 58(1):169-78; discussion 169-78. PubMed ID: 16385341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Listeria-based vaccination against the pericyte antigen RGS5 elicits anti-vascular effects and colon cancer protection.
    Anderson TS; McCormick AL; Daugherity EA; Oladejo M; Okpalanwaka IF; Smith SL; Appiah D; Wood LM; Lowe DB
    Oncoimmunology; 2023; 12(1):2260620. PubMed ID: 37781234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Promises and challenges for the development of Listeria monocytogenes-based immunotherapies.
    Brockstedt DG; Dubensky TW
    Expert Rev Vaccines; 2008 Sep; 7(7):1069-84. PubMed ID: 18767955
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    Jia Q; Masleša-Galić S; Nava S; Horwitz MA
    mBio; 2022 Jun; 13(3):e0068722. PubMed ID: 35642945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myeloid-derived suppressor cells have a central role in attenuated Listeria monocytogenes-based immunotherapy against metastatic breast cancer in young and old mice.
    Chandra D; Jahangir A; Quispe-Tintaya W; Einstein MH; Gravekamp C
    Br J Cancer; 2013 Jun; 108(11):2281-90. PubMed ID: 23640395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple effector mechanisms induced by recombinant Listeria monocytogenes anticancer immunotherapeutics.
    Wallecha A; Carroll KD; Maciag PC; Rivera S; Shahabi V; Paterson Y
    Adv Appl Microbiol; 2009; 66():1-27. PubMed ID: 19203646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Listeria monocytogenes: a potent vaccine vector for neoplastic and infectious disease.
    Weiskirch LM; Paterson Y
    Immunol Rev; 1997 Aug; 158():159-69. PubMed ID: 9314084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Construction and characterization of an attenuated Listeria monocytogenes strain for clinical use in cancer immunotherapy.
    Wallecha A; Maciag PC; Rivera S; Paterson Y; Shahabi V
    Clin Vaccine Immunol; 2009 Jan; 16(1):96-103. PubMed ID: 19020110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Potent and Effective Suicidal
    Hanson WG; Benanti EL; Lemmens EE; Liu W; Skoble J; Leong ML; Rae CS; Fassò M; Brockstedt DG; Chen C; Portnoy DA; Dubensky TW; Lauer P
    Infect Immun; 2019 Aug; 87(8):. PubMed ID: 31235641
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progress towards the use of Listeria monocytogenes as a live bacterial vaccine vector for the delivery of HIV antigens.
    Paterson Y; Johnson RS
    Expert Rev Vaccines; 2004 Aug; 3(4 Suppl):S119-34. PubMed ID: 15285711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A listeriolysin O subunit vaccine is protective against Listeria monocytogenes.
    Phelps CC; Vadia S; Boyaka PN; Varikuti S; Attia Z; Dubey P; Satoskar AR; Tweten R; Seveau S
    Vaccine; 2020 Aug; 38(36):5803-5813. PubMed ID: 32684498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Listeria monocytogenes and the Inflammasome: From Cytosolic Bacteriolysis to Tumor Immunotherapy.
    Theisen E; Sauer JD
    Curr Top Microbiol Immunol; 2016; 397():133-60. PubMed ID: 27460808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccine strain Listeria monocytogenes bacteremia occurring 31 months after immunization.
    Fares E; McCloskey CB; Gutierrez A; Princiotta M; Salinas LJ; Drevets DA
    Infection; 2019 Jun; 47(3):489-492. PubMed ID: 30430399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravenous Delivery of Living
    Liu Y; Lu Y; Ning B; Su X; Yang B; Dong H; Yin B; Pang Z; Shen S
    ACS Nano; 2022 Mar; 16(3):4102-4115. PubMed ID: 35262333
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Genetically Modified attenuated
    Jia YY; Tan WJ; Duan FF; Pan ZM; Chen X; Yin YL; Jiao XA
    Front Cell Infect Microbiol; 2017; 7():279. PubMed ID: 28706878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Live, attenuated strains of Listeria and Salmonella as vaccine vectors in cancer treatment.
    Shahabi V; Maciag PC; Rivera S; Wallecha A
    Bioeng Bugs; 2010; 1(4):235-43. PubMed ID: 21327055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Priming and activation of human ovarian and breast cancer-specific CD8+ T cells by polyvalent Listeria monocytogenes-based vaccines.
    Sinnathamby G; Lauer P; Zerfass J; Hanson B; Karabudak A; Krakover J; Secord AA; Clay TM; Morse MA; Dubensky TW; Brockstedt DG; Philip R; Giedlin M
    J Immunother; 2009 Oct; 32(8):856-69. PubMed ID: 19752748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.